{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:33:50Z","timestamp":1791387230450,"version":"4.3.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Pertussis is a highly contagious disease of public health interest caused by the bacterium <jats:italic>Bordetella pertussis<\/jats:italic>. Although its incidence has decreased substantially after the introduction of a vaccination, the burden of the disease remains high. Although the paroxysmal phase is highly disabling, complications are uncommon and more prevalent in children than in adults. The most frequent neurological complication is encephalopathy, but seizures, paresis, paraplegia, ataxias, aphasias, and decerebration postures have also been described. The complication of decerebration postures has not been previously reported in adults.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>We present a video case of an adult HIV patient with severe coughing paroxysms, post-tussive emesis and syncope, whose workup confirmed the diagnosis of a <jats:italic>B. pertussis<\/jats:italic> respiratory infection. During hospitalization, he had fluctuant encephalopathy and post-tussive decerebration postures following paroxysms. He was treated with antibiotic therapy and finally sent home without residual neurological deficits.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>This case illustrates the biological plausibility of neurologic complications of pertussis in adults, which, albeit rare, can cause important morbidities. Future research should explore whether there are differences in the clinical presentation, risk factors and pathophysiology of the disease among adults or interventions aimed at preventing or treating pertussis encephalopathy.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12879-020-05198-x","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T09:25:31Z","timestamp":1593681931000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neurologic alterations in an HIV adult patient with pertussis: a case report"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3494-0810","authenticated-orcid":false,"given":"Mar\u00eda Camila","family":"Arango-Granados","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n Mauricio","family":"Trompa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,2]]},"reference":[{"issue":"7","key":"5198_CR1","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S1473-3099(03)00669-8","volume":"3","author":"NS Crowcroft","year":"2003","unstructured":"Crowcroft NS, Stein C, Duclos P, Birmingham M. How best to estimate the global burden of pertussis? Lancet Infect Dis. 2003;3(7):413\u20138.","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"5198_CR2","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1001\/jama.2010.1181","volume":"304","author":"PB Cornia","year":"2010","unstructured":"Cornia PB, Hersh AL, Lipsky BA, Newman TB, Gonzales R. Does this coughing adolescent or adult patient have pertussis? JAMA. 2010;304(8):890\u20136.","journal-title":"JAMA."},{"issue":"4 Pt 1","key":"5198_CR3","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1542\/peds.102.4.986","volume":"102","author":"CC Grant","year":"1998","unstructured":"Grant CC, McKay EJ, Simpson A, Buckley D. Pertussis encephalopathy with high cerebrospinal fluid antibody titers to pertussis toxin and filamentous hemagglutinin. Pediatrics. 1998;102(4 Pt 1):986\u201390.","journal-title":"Pediatrics."},{"key":"5198_CR4","first-page":"381","volume":"76","author":"H Zellweger","year":"1959","unstructured":"Zellweger H. Pertussis encephalopathy. Arch Pediatr. 1959;76:381\u20136.","journal-title":"Arch Pediatr"},{"key":"5198_CR5","doi-asserted-by":"crossref","unstructured":"Leber AL, Everhart K, Daly JA, Hopper A, Harrington A, Schreckenberger P, et al. Multicenter Evaluation of BioFire FilmArray Respiratory Panel 2 for Detection of Viruses and Bacteria in Nasopharyngeal Swab Samples. J Clin Microbiol. 2018;56(6):e01945\u201317.","DOI":"10.1128\/JCM.01945-17"},{"issue":"4","key":"5198_CR6","doi-asserted-by":"publisher","first-page":"e0195979","DOI":"10.1371\/journal.pone.0195979","volume":"13","author":"AD Lee","year":"2018","unstructured":"Lee AD, Cassiday PK, Pawloski LC, Tatti KM, Martin MD, Briere EC, et al. Clinical evaluation and validation of laboratory methods for the diagnosis of Bordetella pertussis infection: culture, polymerase chain reaction (PCR) and anti-pertussis toxin IgG serology (IgG-PT). PLoS One. 2018;13(4):e0195979.","journal-title":"PLoS One"},{"issue":"3","key":"5198_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1086\/341511","volume":"186","author":"S Gilberg","year":"2002","unstructured":"Gilberg S, Njamkepo E, Du Ch\u00e2telet IP, Partouche H, Gueirard P, Ghasarossian C, et al. Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a french area with very high whole-cell vaccine coverage. J Infect Dis. 2002;186(3):415\u20138.","journal-title":"J Infect Dis"},{"key":"5198_CR8","first-page":"1588","volume-title":"Pertussis and other Bordetella infections. Textbook of pediatric infectious diseases","author":"JD Cherry","year":"2004","unstructured":"Cherry JD, Heininger U. Pertussis and other Bordetella infections. Textbook of pediatric infectious diseases. 5th ed. Philadelphia: The W. B. Saunders Co; 2004. p. 1588\u2013608.","edition":"5"},{"issue":"2","key":"5198_CR9","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1128\/CMR.18.2.326-382.2005","volume":"18","author":"S Mattoo","year":"2005","unstructured":"Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev. 2005;18(2):326\u201382.","journal-title":"Clin Microbiol Rev"},{"issue":"18","key":"5198_CR10","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1001\/jama.298.18.2155","volume":"298","author":"SW Roush","year":"2007","unstructured":"Roush SW, Murphy TV, Group V-PDTW. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA. 2007;298(18):2155\u201363.","journal-title":"JAMA."},{"issue":"2","key":"5198_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.amjmed.2011.05.008","volume":"125","author":"RD Paisley","year":"2012","unstructured":"Paisley RD, Blaylock J, Hartzell JD. Whooping cough in adults: an update on a reemerging infection. Am J Med. 2012;125(2):141\u20133.","journal-title":"Am J Med"},{"issue":"5","key":"5198_CR12","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1378\/chest.115.5.1254","volume":"115","author":"E Yaari","year":"1999","unstructured":"Yaari E, Yafe-Zimerman Y, Schwartz SB, Slater PE, Shvartzman P, Andoren N, et al. Clinical manifestations of Bordetella pertussis infection in immunized children and young adults. Chest. 1999;115(5):1254\u20138.","journal-title":"Chest."},{"issue":"1","key":"5198_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12879-019-3671-6","volume":"19","author":"S Saiki-Macedo","year":"2019","unstructured":"Saiki-Macedo S, Valverde-Ezeta J, Cornejo-Tapia A, Castillo ME, Petrozzi-Helasvuo V, Aguilar-Luis MA, et al. Identfication of viral and bacterial etiologic agents of the pertussis-like syndrome in children under 5\u2009years old hospitalized. BMC Infect Dis. 2019;19(1):75.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"5198_CR14","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3122\/jabfm.2017.03.160330","volume":"30","author":"MH Ebell","year":"2017","unstructured":"Ebell MH, Marchello C, Callahan M. Clinical diagnosis of Bordetella pertussis infection: a systematic review. J Am Board Fam Med. 2017;30(3):308\u201319.","journal-title":"J Am Board Fam Med"},{"key":"5198_CR15","doi-asserted-by":"crossref","unstructured":"Leber AL, Lisby JG, Hansen G, Relich RF, Schneider UV, Granato P, et al. Multicenter Evaluation of the QIAstat-Dx Respiratory Panel for Detection of Viruses and Bacteria in Nasopharyngeal Swab Specimens. J Clin Microbiol. 2020;58(5):e00155\u201320.","DOI":"10.1128\/JCM.00155-20"},{"issue":"5","key":"5198_CR16","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1136\/jclinpath-2014-202833","volume":"68","author":"RC Jerris","year":"2015","unstructured":"Jerris RC, Williams SR, MacDonald HJ, Ingebrigtsen DR, Westblade LF, Rogers BB. Testing implications of varying targets for Bordetella pertussis: comparison of the FilmArray respiratory panel and the focus B. pertussis PCR assay. J Clin Pathol. 2015;68(5):394\u20136.","journal-title":"J Clin Pathol"},{"issue":"3","key":"5198_CR17","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.diagmicrobio.2008.02.017","volume":"61","author":"KM Tatti","year":"2008","unstructured":"Tatti KM, Wu KH, Tondella ML, Cassiday PK, Cortese MM, Wilkins PP, et al. Development and evaluation of dual-target real-time polymerase chain reaction assays to detect Bordetella spp. Diagn Microbiol Infect Dis. 2008;61(3):264\u201372.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"5198_CR18","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/clinids\/13.6.1043","volume":"13","author":"SA Halperin","year":"1991","unstructured":"Halperin SA, Marrie TJ. Pertussis encephalopathy in an adult: case report and review. Rev Infect Dis. 1991;13(6):1043\u20137.","journal-title":"Rev Infect Dis"},{"issue":"2","key":"5198_CR19","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/BF01644321","volume":"16","author":"JE Hoppe","year":"1988","unstructured":"Hoppe JE, Haug A. Antimicrobial susceptibility of Bordetella pertussis (part I). Infection. 1988;16(2):126\u201330.","journal-title":"Infection."},{"issue":"7","key":"5198_CR20","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/BF01968151","volume":"8","author":"JE Hoppe","year":"1989","unstructured":"Hoppe JE, Eichhorn A. Activity of new macrolides against Bordetella pertussis and Bordetella parapertussis. Eur J Clin Microbiol Infect Dis. 1989;8(7):653\u20134.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"5198_CR21","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/BF02962373","volume":"26","author":"JE Hoppe","year":"1998","unstructured":"Hoppe JE. State of art in antibacterial susceptibility of Bordetella pertussis and antibiotic treatment of pertussis. Infection. 1998;26(4):242\u20136.","journal-title":"Infection."},{"issue":"5","key":"5198_CR22","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1097\/00006454-198705000-00009","volume":"6","author":"SO Bergquist","year":"1987","unstructured":"Bergquist SO, Bernander S, Dahnsj\u00f6 H, Sundel\u00f6f B. Erythromycin in the treatment of pertussis: a study of bacteriologic and clinical effects. Pediatr Infect Dis J. 1987;6(5):458\u201361.","journal-title":"Pediatr Infect Dis J"},{"issue":"RR-14","key":"5198_CR23","first-page":"1","volume":"54","author":"T Tiwari","year":"2005","unstructured":"Tiwari T, Murphy TV, Moran J. National Immunization Program CDC. Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC Guidelines. MMWR Recomm Rep. 2005;54(RR-14):1\u201316.","journal-title":"MMWR Recomm Rep"},{"issue":"4","key":"5198_CR24","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/BF01639525","volume":"17","author":"JE Hoppe","year":"1989","unstructured":"Hoppe JE, Halm U, Hagedorn HJ, Kraminer-Hagedorn A. Comparison of erythromycin ethylsuccinate and co-trimoxazole for treatment of pertussis. Infection. 1989;17(4):227\u201331.","journal-title":"Infection."},{"key":"5198_CR25","volume-title":"Mandell, Douglas, and Bennett's principles and practice of infectious diseases","author":"J Bennett","year":"2020","unstructured":"Bennett J, Dolin R, Blaser M. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 9th ed. Philadelphia: Elsevier; 2020.","edition":"9"},{"key":"5198_CR26","first-page":"CD003257","volume":"5","author":"S Bettiol","year":"2012","unstructured":"Bettiol S, Wang K, Thompson MJ, Roberts NW, Perera R, Heneghan CJ, et al. Symptomatic treatment of the cough in whooping cough. Cochrane Database Syst Rev. 2012;5:CD003257.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"5198_CR27","doi-asserted-by":"publisher","first-page":"e816","DOI":"10.1542\/peds.2009-2860","volume":"126","author":"HE Rowlands","year":"2010","unstructured":"Rowlands HE, Goldman AP, Harrington K, Karimova A, Brierley J, Cross N, et al. Impact of rapid leukodepletion on the outcome of severe clinical pertussis in young infants. Pediatrics. 2010;126(4):e816\u201327.","journal-title":"Pediatrics."},{"issue":"3","key":"5198_CR28","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/PCC.0000000000001454","volume":"19","author":"M Domico","year":"2018","unstructured":"Domico M, Ridout D, MacLaren G, Barbaro R, Annich G, Schlapbach LJ, et al. Extracorporeal membrane oxygenation for pertussis: predictors of outcome including pulmonary hypertension and Leukodepletion. Pediatr Crit Care Med. 2018;19(3):254\u201361.","journal-title":"Pediatr Crit Care Med"},{"issue":"6","key":"5198_CR29","doi-asserted-by":"publisher","DOI":"10.1542\/peds.100.6.e10","volume":"100","author":"U Heininger","year":"1997","unstructured":"Heininger U, Klich K, Stehr K, Cherry JD. Clinical findings in Bordetella pertussis infections: results of a prospective multicenter surveillance study. Pediatrics. 1997;100(6):E10.","journal-title":"Pediatrics."},{"issue":"2","key":"5198_CR30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1046\/j.1440-1843.2003.00459.x","volume":"8","author":"G Hodge","year":"2003","unstructured":"Hodge G, Hodge S, Markus C, Lawrence A, Han P. A marked decrease in L-selectin expression by leucocytes in infants with Bordetella pertussis infection: leucocytosis explained? Respirology. 2003;8(2):157\u201362.","journal-title":"Respirology."},{"key":"5198_CR31","doi-asserted-by":"crossref","unstructured":"Carbonetti NH. Pertussis leukocytosis: mechanisms, clinical relevance and treatment. Pathog Dis. 2016;74(7):ftw087.","DOI":"10.1093\/femspd\/ftw087"},{"issue":"suppl 4","key":"5198_CR32","doi-asserted-by":"publisher","first-page":"S174","DOI":"10.1093\/cid\/ciw527","volume":"63","author":"MC Nunes","year":"2016","unstructured":"Nunes MC, Downs S, Jones S, van Niekerk N, Cutland CL, Madhi SA. Bordetella pertussis infection in south African HIV-infected and HIV-uninfected mother-infant dyads: a longitudinal cohort study. Clin Infect Dis. 2016;63(suppl 4):S174\u2013S80.","journal-title":"Clin Infect Dis"},{"key":"5198_CR33","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ijid.2018.01.010","volume":"68","author":"NM du Plessis","year":"2018","unstructured":"du Plessis NM, Ntshoe G, Reubenson G, Kularatne R, Blumberg L, Thomas J, et al. Risk factors for pertussis among hospitalized children in a high HIV prevalence setting, South Africa. Int J Infect Dis. 2018;68:54\u201360.","journal-title":"Int J Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05198-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-05198-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05198-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T23:21:14Z","timestamp":1625181674000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05198-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,2]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5198"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05198-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,2]]},"assertion":[{"value":"18 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This manuscript was approved by the IPS Universtaria Le\u00f3n XIII Investigation Committee (Medell\u00edn, Colombia).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient provided written consent for the publication of the information, images and video files related to his case.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"471"}}